Cline Scientific
Cline Scientific receives Decision to Grant for StemCART in Europe
The patent application is titled "A method for providing a cartilage implant with chondrocytes". The decision will take effect from the 14th of June 2023.
The notice of allowance for this patent was received from EPO and a press release was sent out in April.
More about StemCART
StemCART is a preclinical Advanced Therapy Medicinal Product (ATMP) that aims to revolutionize the treatment of cartilage damage for patients worldwide.
For more information, please contact:
Hanne Evenbratt, Interim CEO and VP – Research & Development
Email: hanne.evenbratt@clinescientific.com
Phone: +46 704 88 79 23
Datum | 2023-05-23, kl 14:50 |
Källa | Cision |
